Utility of promoter hypermethylation in malignant risk stratification of intraductal papillary mucinous neoplasms

HIGHLIGHTS

  • who: Ankit Chhoda from the This study received ethics approval from Institutional Review Board (IRB#2000022652) at Yale University have published the research work: Utility of promoter hypermethylation in malignant risk stratification of intraductal papillary mucinous neoplasms, in the Journal: IPMN Lesion u00adSize#
  • what: This study investigates the DNA methylation-based PC panel (ADAMTS1 BNC1 and CACNA1G genes) in differentiating IPMN-advanced neoplasia from IPMN-LGDs. IPMN stratification into LGD and advanced neoplasia is a critical domain which warrants dedicated research and has been the focus of this study. This study investigates the diagnostic utility . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?